ARTICLE | Company News
Immusol, NVS oncology deal
October 1, 2001 7:00 AM UTC
Immusol (San Diego, Calif.) will use its Inverse Genomics gene inactivation technology to discover cancer drug targets for Novartis (NVS). Immusol will receive upfront R&D funding and an equity invest...